1. 1298Associations of DMT therapies with COVID-19 severity in multiple sclerosis. (2nd September 2021) Authors: Simpson-Yap, Steve; Brouwer, Edward De; Kalincik, Tomas; Rijke, Nick; Hillert, Jan; Walton, Clare; Edan, Gilles; Spelman, Tim; Geyes, Lotte; Parciak, Tina; Gautrais, Clément; Lazovski, Nikola; Pirmani, Ashkan; Ardeshirdavani, Amin; Forsberg, Lars; Glaser, Anna; McBurney, Robert; Schmidt, Hollie; ... Journal: International journal of epidemiology Issue: Volume 50(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A comparative study of teriflunomide and dimethyl fumarate within the Swedish MS Registry. (February 2022) Authors: Hillert, Jan; Tsai, Jon A; Nouhi, Mona; Glaser, Anna; Spelman, Tim Journal: Multiple sclerosis Issue: Volume 28:Number 2(2022) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Age Related Multiple Sclerosis Severity Score: Disability ranked by age. (December 2017) Authors: Manouchehrinia, Ali; Westerlind, Helga; Kingwell, Elaine; Zhu, Feng; Carruthers, Robert; Ramanujam, Ryan; Ban, Maria; Glaser, Anna; Sawcer, Stephen; Tremlett, Helen; Hillert, Jan Journal: Multiple sclerosis Issue: Volume 23:Number 14(2017) Page Start: 1938 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis. (9th November 2021) Authors: Simpson-Yap, Steve; De Brouwer, Edward; Kalincik, Tomas; Rijke, Nick; Hillert, Jan A.; Walton, Clare; Edan, Gilles; Moreau, Yves; Spelman, Tim; Geys, Lotte; Parciak, Tina; Gautrais, Clement; Lazovski, Nikola; Pirmani, Ashkan; Ardeshirdavanai, Amin; Forsberg, Lars; Glaser, Anna; McBurney, Robert; ... Journal: Neurology Issue: Volume 97:Number 19(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis. (9th November 2021) Authors: Simpson-Yap, Steve; De Brouwer, Edward; Kalincik, Tomas; Rijke, Nick; Hillert, Jan A.; Walton, Clare; Edan, Gilles; Moreau, Yves; Spelman, Tim; Geys, Lotte; Parciak, Tina; Gautrais, Clement; Lazovski, Nikola; Pirmani, Ashkan; Ardeshirdavanai, Amin; Forsberg, Lars; Glaser, Anna; McBurney, Robert; ... Journal: Neurology Issue: Volume 97:Number 19(2021) Page Start: e1870 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cognitive function is a major determinant of income among multiple sclerosis patients in Sweden acting independently from physical disability. (January 2019) Authors: Kavaliunas, Andrius; Danylaite Karrenbauer, Virginija; Gyllensten, Hanna; Manouchehrinia, Ali; Glaser, Anna; Olsson, Tomas; Alexanderson, Kristina; Hillert, Jan Journal: Multiple sclerosis Issue: Volume 25:Number 1(2019) Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Copy number variations across the blood–brain barrier in multiple sclerosis. Issue 7 (13th May 2022) Authors: Bedri, Sahl Khalid; Evertsson, Björn; Khademi, Mohsen; Al Nimer, Faiez; Olsson, Tomas; Hillert, Jan; Glaser, Anna Journal: Annals of clinical and translational neurology Issue: Volume 9:Issue 7(2022) Page Start: 962 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Enabling nanotechnology entrepreneurship in a French context: Towards a holistic theoretical framework. Issue 4 (21st November 2016) Authors: Glaser, Anna; Ben Slimane, Sonia; Auplat, Claire; Coeurderoy, Régis Journal: Journal of small business and enterprise development Issue: Volume 23:Issue 4(2016) Page Start: 1009 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Importance of early treatment initiation in the clinical course of multiple sclerosis. (August 2017) Authors: Kavaliunas, Andrius; Manouchehrinia, Ali; Stawiarz, Leszek; Ramanujam, Ryan; Agholme, Jonas; Hedström, Anna Karin; Beiki, Omid; Glaser, Anna; Hillert, Jan Journal: Multiple sclerosis Issue: Volume 23:Number 9(2017) Page Start: 1233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry. (June 2022) Authors: Spelman, Tim; Forsberg, Lars; McKay, Kyla; Glaser, Anna; Hillert, Jan Journal: Multiple sclerosis Issue: Volume 28:Number 7(2022) Page Start: 1051 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗